nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—nephron tubule—kidney cancer	0.0295	0.374	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ALDH1A1—kidney cancer	0.0272	0.138	CbGpPWpGaD
Icosapent ethyl—DGAT1—cortex of kidney—kidney cancer	0.0252	0.321	CbGeAlD
Icosapent ethyl—DGAT1—cardiac atrium—kidney cancer	0.024	0.305	CbGeAlD
Icosapent ethyl—DGAT1—Statin Pathway—SCARB1—kidney cancer	0.0208	0.105	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CRABP1—kidney cancer	0.0189	0.0956	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.0152	0.0768	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—GLIPR1—kidney cancer	0.011	0.0555	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—ACHE—kidney cancer	0.00903	0.0457	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—BCHE—kidney cancer	0.00786	0.0398	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—ACHE—kidney cancer	0.0063	0.0319	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—kidney cancer	0.00601	0.0304	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—BCHE—kidney cancer	0.00549	0.0278	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS1—kidney cancer	0.00513	0.357	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00437	0.0221	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.00408	0.0206	CbGpPWpGaD
Icosapent ethyl—Icosapent—PTGS1—kidney cancer	0.00402	0.28	CrCbGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.00308	0.0156	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—kidney cancer	0.00293	0.204	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—ACY1—kidney cancer	0.00281	0.0142	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00239	0.0121	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PDHB—kidney cancer	0.00239	0.0121	CbGpPWpGaD
Icosapent ethyl—Icosapent—PTGS2—kidney cancer	0.0023	0.16	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—CCBL1—kidney cancer	0.00224	0.0114	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00203	0.0103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PTEN—kidney cancer	0.00197	0.00999	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GLIPR1—kidney cancer	0.00194	0.00985	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPAT—kidney cancer	0.00194	0.00985	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.00192	0.00972	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.0019	0.00963	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FH—kidney cancer	0.00181	0.00916	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APRT—kidney cancer	0.00181	0.00916	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00177	0.00895	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPC3—kidney cancer	0.0017	0.00861	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA2—kidney cancer	0.00165	0.00837	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALAD—kidney cancer	0.00161	0.00816	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ST3GAL2—kidney cancer	0.00157	0.00796	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALDH1A1—kidney cancer	0.00154	0.00778	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC5A3—kidney cancer	0.00147	0.00746	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PGK1—kidney cancer	0.00147	0.00746	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LDHB—kidney cancer	0.00145	0.00732	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—kidney cancer	0.00139	0.00705	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA9—kidney cancer	0.00125	0.00635	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.00122	0.0062	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CRABP1—kidney cancer	0.00107	0.0054	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ITPR2—kidney cancer	0.00099	0.00502	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000913	0.00462	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTT1—kidney cancer	0.000903	0.00457	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACHE—kidney cancer	0.000903	0.00457	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SCARB1—kidney cancer	0.000855	0.00433	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS1—kidney cancer	0.000846	0.00429	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PSMD7—kidney cancer	0.00083	0.0042	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BCHE—kidney cancer	0.000787	0.00399	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC5A5—kidney cancer	0.000777	0.00394	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC2A1—kidney cancer	0.000751	0.0038	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000728	0.00369	CbGpPWpGaD
Icosapent ethyl—Anorexia—Dactinomycin—kidney cancer	0.000717	0.00101	CcSEcCtD
Icosapent ethyl—Neoplasm—Doxorubicin—kidney cancer	0.000716	0.00101	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000713	0.00101	CcSEcCtD
Icosapent ethyl—Hypertension—Vincristine—kidney cancer	0.000711	0.001	CcSEcCtD
Icosapent ethyl—Dyspnoea—Sunitinib—kidney cancer	0.000709	0.000999	CcSEcCtD
Icosapent ethyl—Constipation—Sorafenib—kidney cancer	0.000706	0.000996	CcSEcCtD
Icosapent ethyl—Pain—Sorafenib—kidney cancer	0.000706	0.000996	CcSEcCtD
Icosapent ethyl—Malaise—Gemcitabine—kidney cancer	0.000705	0.000993	CcSEcCtD
Icosapent ethyl—Myalgia—Vincristine—kidney cancer	0.000701	0.000989	CcSEcCtD
Icosapent ethyl—Dyspepsia—Sunitinib—kidney cancer	0.0007	0.000986	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Capecitabine—kidney cancer	0.000695	0.00098	CcSEcCtD
Icosapent ethyl—Pneumonia—Capecitabine—kidney cancer	0.000691	0.000974	CcSEcCtD
Icosapent ethyl—Decreased appetite—Sunitinib—kidney cancer	0.000691	0.000974	CcSEcCtD
Icosapent ethyl—Infestation NOS—Capecitabine—kidney cancer	0.000687	0.000969	CcSEcCtD
Icosapent ethyl—Infestation—Capecitabine—kidney cancer	0.000687	0.000969	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000686	0.000967	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000686	0.000966	CcSEcCtD
Icosapent ethyl—Asthenia—Vinblastine—kidney cancer	0.000685	0.000966	CcSEcCtD
Icosapent ethyl—Asthenia—Everolimus—kidney cancer	0.000683	0.000963	CcSEcCtD
Icosapent ethyl—Cough—Gemcitabine—kidney cancer	0.000682	0.000961	CcSEcCtD
Icosapent ethyl—Constipation—Sunitinib—kidney cancer	0.00068	0.000958	CcSEcCtD
Icosapent ethyl—Pain—Sunitinib—kidney cancer	0.00068	0.000958	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Capecitabine—kidney cancer	0.000677	0.000955	CcSEcCtD
Icosapent ethyl—Hypertension—Gemcitabine—kidney cancer	0.000675	0.000951	CcSEcCtD
Icosapent ethyl—Chills—Paclitaxel—kidney cancer	0.000674	0.000951	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Doxorubicin—kidney cancer	0.000674	0.00095	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Capecitabine—kidney cancer	0.000674	0.000949	CcSEcCtD
Icosapent ethyl—Pruritus—Everolimus—kidney cancer	0.000673	0.000949	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Vincristine—kidney cancer	0.000672	0.000948	CcSEcCtD
Icosapent ethyl—Oedema—Vincristine—kidney cancer	0.000672	0.000948	CcSEcCtD
Icosapent ethyl—Arrhythmia—Paclitaxel—kidney cancer	0.000671	0.000947	CcSEcCtD
Icosapent ethyl—Infection—Vincristine—kidney cancer	0.000668	0.000942	CcSEcCtD
Icosapent ethyl—Arthralgia—Gemcitabine—kidney cancer	0.000665	0.000938	CcSEcCtD
Icosapent ethyl—Chest pain—Gemcitabine—kidney cancer	0.000665	0.000938	CcSEcCtD
Icosapent ethyl—Myalgia—Gemcitabine—kidney cancer	0.000665	0.000938	CcSEcCtD
Icosapent ethyl—Alopecia—Paclitaxel—kidney cancer	0.000664	0.000936	CcSEcCtD
Icosapent ethyl—Asthenia—Erlotinib—kidney cancer	0.000659	0.000929	CcSEcCtD
Icosapent ethyl—Discomfort—Gemcitabine—kidney cancer	0.000657	0.000927	CcSEcCtD
Icosapent ethyl—Malnutrition—Paclitaxel—kidney cancer	0.000654	0.000922	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dactinomycin—kidney cancer	0.000654	0.000922	CcSEcCtD
Icosapent ethyl—Body temperature increased—Sorafenib—kidney cancer	0.000653	0.000921	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Vincristine—kidney cancer	0.00065	0.000916	CcSEcCtD
Icosapent ethyl—Pruritus—Erlotinib—kidney cancer	0.00065	0.000916	CcSEcCtD
Icosapent ethyl—Epistaxis—Capecitabine—kidney cancer	0.000648	0.000914	CcSEcCtD
Icosapent ethyl—Pain—Dactinomycin—kidney cancer	0.000644	0.000907	CcSEcCtD
Icosapent ethyl—Anorexia—Vincristine—kidney cancer	0.000641	0.000903	CcSEcCtD
Icosapent ethyl—Dysgeusia—Paclitaxel—kidney cancer	0.000641	0.000903	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—kidney cancer	0.00064	0.000902	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Gemcitabine—kidney cancer	0.000638	0.000899	CcSEcCtD
Icosapent ethyl—Oedema—Gemcitabine—kidney cancer	0.000638	0.000899	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000635	0.00322	CbGpPWpGaD
Icosapent ethyl—Infection—Gemcitabine—kidney cancer	0.000634	0.000893	CcSEcCtD
Icosapent ethyl—Back pain—Paclitaxel—kidney cancer	0.000633	0.000892	CcSEcCtD
Icosapent ethyl—Dizziness—Vinblastine—kidney cancer	0.000632	0.000891	CcSEcCtD
Icosapent ethyl—Dizziness—Everolimus—kidney cancer	0.000629	0.000887	CcSEcCtD
Icosapent ethyl—Body temperature increased—Sunitinib—kidney cancer	0.000628	0.000886	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GSTP1—kidney cancer	0.000626	0.00317	CbGpPWpGaD
Icosapent ethyl—Feeling abnormal—Dactinomycin—kidney cancer	0.00062	0.000874	CcSEcCtD
Icosapent ethyl—Rhinitis—Capecitabine—kidney cancer	0.000618	0.000872	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Gemcitabine—kidney cancer	0.000617	0.000869	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000613	0.000864	CcSEcCtD
Icosapent ethyl—Pharyngitis—Capecitabine—kidney cancer	0.000612	0.000863	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—kidney cancer	0.000612	0.000862	CcSEcCtD
Icosapent ethyl—Insomnia—Vincristine—kidney cancer	0.000608	0.000857	CcSEcCtD
Icosapent ethyl—Anorexia—Gemcitabine—kidney cancer	0.000608	0.000857	CcSEcCtD
Icosapent ethyl—Vomiting—Vinblastine—kidney cancer	0.000607	0.000856	CcSEcCtD
Icosapent ethyl—Dizziness—Erlotinib—kidney cancer	0.000607	0.000856	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Paclitaxel—kidney cancer	0.000607	0.000856	CcSEcCtD
Icosapent ethyl—Vomiting—Everolimus—kidney cancer	0.000605	0.000853	CcSEcCtD
Icosapent ethyl—Rash—Everolimus—kidney cancer	0.0006	0.000846	CcSEcCtD
Icosapent ethyl—Dermatitis—Everolimus—kidney cancer	0.0006	0.000845	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dactinomycin—kidney cancer	0.000595	0.000839	CcSEcCtD
Icosapent ethyl—Asthenia—Sorafenib—kidney cancer	0.000593	0.000836	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ABCB1—kidney cancer	0.000593	0.003	CbGpPWpGaD
Icosapent ethyl—Malaise—Paclitaxel—kidney cancer	0.00059	0.000832	CcSEcCtD
Icosapent ethyl—Vertigo—Paclitaxel—kidney cancer	0.000588	0.000829	CcSEcCtD
Icosapent ethyl—Syncope—Paclitaxel—kidney cancer	0.000587	0.000827	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vincristine—kidney cancer	0.000584	0.000824	CcSEcCtD
Icosapent ethyl—Pruritus—Sorafenib—kidney cancer	0.000584	0.000824	CcSEcCtD
Icosapent ethyl—Vomiting—Erlotinib—kidney cancer	0.000584	0.000823	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000581	0.000819	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Vincristine—kidney cancer	0.00058	0.000818	CcSEcCtD
Icosapent ethyl—Rash—Erlotinib—kidney cancer	0.000579	0.000816	CcSEcCtD
Icosapent ethyl—Dermatitis—Erlotinib—kidney cancer	0.000578	0.000815	CcSEcCtD
Icosapent ethyl—Insomnia—Gemcitabine—kidney cancer	0.000577	0.000813	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—kidney cancer	0.000575	0.00291	CbGpPWpGaD
Icosapent ethyl—Loss of consciousness—Paclitaxel—kidney cancer	0.000575	0.000811	CcSEcCtD
Icosapent ethyl—Pain—Vincristine—kidney cancer	0.000575	0.00081	CcSEcCtD
Icosapent ethyl—Constipation—Vincristine—kidney cancer	0.000575	0.00081	CcSEcCtD
Icosapent ethyl—Cough—Paclitaxel—kidney cancer	0.000571	0.000805	CcSEcCtD
Icosapent ethyl—Asthenia—Sunitinib—kidney cancer	0.00057	0.000804	CcSEcCtD
Icosapent ethyl—Dyspnoea—Gemcitabine—kidney cancer	0.000569	0.000802	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—kidney cancer	0.000566	0.000797	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—kidney cancer	0.000566	0.000797	CcSEcCtD
Icosapent ethyl—Hypertension—Paclitaxel—kidney cancer	0.000565	0.000796	CcSEcCtD
Icosapent ethyl—Pruritus—Sunitinib—kidney cancer	0.000562	0.000793	CcSEcCtD
Icosapent ethyl—Chest pain—Paclitaxel—kidney cancer	0.000557	0.000785	CcSEcCtD
Icosapent ethyl—Myalgia—Paclitaxel—kidney cancer	0.000557	0.000785	CcSEcCtD
Icosapent ethyl—Arthralgia—Paclitaxel—kidney cancer	0.000557	0.000785	CcSEcCtD
Icosapent ethyl—Decreased appetite—Gemcitabine—kidney cancer	0.000554	0.000782	CcSEcCtD
Icosapent ethyl—Chills—Capecitabine—kidney cancer	0.000553	0.00078	CcSEcCtD
Icosapent ethyl—Arrhythmia—Capecitabine—kidney cancer	0.000551	0.000777	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000551	0.000776	CcSEcCtD
Icosapent ethyl—Discomfort—Paclitaxel—kidney cancer	0.00055	0.000776	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—kidney cancer	0.000547	0.00077	CcSEcCtD
Icosapent ethyl—Dizziness—Sorafenib—kidney cancer	0.000546	0.00077	CcSEcCtD
Icosapent ethyl—Pain—Gemcitabine—kidney cancer	0.000545	0.000769	CcSEcCtD
Icosapent ethyl—Constipation—Gemcitabine—kidney cancer	0.000545	0.000769	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP1A1—kidney cancer	0.000545	0.00276	CbGpPWpGaD
Icosapent ethyl—Alopecia—Capecitabine—kidney cancer	0.000545	0.000768	CcSEcCtD
Icosapent ethyl—Dry mouth—Paclitaxel—kidney cancer	0.000545	0.000768	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—kidney cancer	0.000544	0.000768	CcSEcCtD
Icosapent ethyl—Asthenia—Dactinomycin—kidney cancer	0.00054	0.000761	CcSEcCtD
Icosapent ethyl—Malnutrition—Capecitabine—kidney cancer	0.000537	0.000757	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Paclitaxel—kidney cancer	0.000534	0.000753	CcSEcCtD
Icosapent ethyl—Oedema—Paclitaxel—kidney cancer	0.000534	0.000753	CcSEcCtD
Icosapent ethyl—Body temperature increased—Vincristine—kidney cancer	0.000532	0.000749	CcSEcCtD
Icosapent ethyl—Infection—Paclitaxel—kidney cancer	0.000531	0.000748	CcSEcCtD
Icosapent ethyl—Dysgeusia—Capecitabine—kidney cancer	0.000526	0.000741	CcSEcCtD
Icosapent ethyl—Dizziness—Sunitinib—kidney cancer	0.000526	0.000741	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Gemcitabine—kidney cancer	0.000526	0.000741	CcSEcCtD
Icosapent ethyl—Shock—Paclitaxel—kidney cancer	0.000525	0.000741	CcSEcCtD
Icosapent ethyl—Vomiting—Sorafenib—kidney cancer	0.000525	0.00074	CcSEcCtD
Icosapent ethyl—Tachycardia—Paclitaxel—kidney cancer	0.000521	0.000735	CcSEcCtD
Icosapent ethyl—Rash—Sorafenib—kidney cancer	0.000521	0.000734	CcSEcCtD
Icosapent ethyl—Dermatitis—Sorafenib—kidney cancer	0.00052	0.000734	CcSEcCtD
Icosapent ethyl—Back pain—Capecitabine—kidney cancer	0.000519	0.000732	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000518	0.00073	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Paclitaxel—kidney cancer	0.000516	0.000728	CcSEcCtD
Icosapent ethyl—Anorexia—Paclitaxel—kidney cancer	0.000509	0.000718	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—kidney cancer	0.000509	0.000717	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000507	0.000715	CcSEcCtD
Icosapent ethyl—Vomiting—Sunitinib—kidney cancer	0.000505	0.000712	CcSEcCtD
Icosapent ethyl—Body temperature increased—Gemcitabine—kidney cancer	0.000504	0.000711	CcSEcCtD
Icosapent ethyl—Rash—Sunitinib—kidney cancer	0.000501	0.000707	CcSEcCtD
Icosapent ethyl—Dermatitis—Sunitinib—kidney cancer	0.000501	0.000706	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—kidney cancer	0.0005	0.000705	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Capecitabine—kidney cancer	0.000498	0.000702	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—kidney cancer	0.000497	0.0007	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—kidney cancer	0.000497	0.0007	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—kidney cancer	0.000497	0.0007	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—kidney cancer	0.000487	0.000687	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000487	0.000686	CcSEcCtD
Icosapent ethyl—Malaise—Capecitabine—kidney cancer	0.000484	0.000683	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—kidney cancer	0.000484	0.000682	CcSEcCtD
Icosapent ethyl—Insomnia—Paclitaxel—kidney cancer	0.000483	0.000681	CcSEcCtD
Icosapent ethyl—Vertigo—Capecitabine—kidney cancer	0.000482	0.00068	CcSEcCtD
Icosapent ethyl—Asthenia—Vincristine—kidney cancer	0.000482	0.00068	CcSEcCtD
Icosapent ethyl—Syncope—Capecitabine—kidney cancer	0.000482	0.000679	CcSEcCtD
Icosapent ethyl—Vomiting—Dactinomycin—kidney cancer	0.000478	0.000674	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—kidney cancer	0.000478	0.000673	CcSEcCtD
Icosapent ethyl—Dyspnoea—Paclitaxel—kidney cancer	0.000476	0.000671	CcSEcCtD
Icosapent ethyl—Rash—Dactinomycin—kidney cancer	0.000474	0.000669	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Capecitabine—kidney cancer	0.000472	0.000665	CcSEcCtD
Icosapent ethyl—Dyspepsia—Paclitaxel—kidney cancer	0.00047	0.000663	CcSEcCtD
Icosapent ethyl—Cough—Capecitabine—kidney cancer	0.000469	0.000661	CcSEcCtD
Icosapent ethyl—Decreased appetite—Paclitaxel—kidney cancer	0.000464	0.000654	CcSEcCtD
Icosapent ethyl—Hypertension—Capecitabine—kidney cancer	0.000464	0.000654	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000461	0.00065	CcSEcCtD
Icosapent ethyl—Asthenia—Gemcitabine—kidney cancer	0.000458	0.000645	CcSEcCtD
Icosapent ethyl—Myalgia—Capecitabine—kidney cancer	0.000457	0.000644	CcSEcCtD
Icosapent ethyl—Arthralgia—Capecitabine—kidney cancer	0.000457	0.000644	CcSEcCtD
Icosapent ethyl—Chest pain—Capecitabine—kidney cancer	0.000457	0.000644	CcSEcCtD
Icosapent ethyl—Pain—Paclitaxel—kidney cancer	0.000457	0.000644	CcSEcCtD
Icosapent ethyl—Constipation—Paclitaxel—kidney cancer	0.000457	0.000644	CcSEcCtD
Icosapent ethyl—Discomfort—Capecitabine—kidney cancer	0.000452	0.000637	CcSEcCtD
Icosapent ethyl—Pruritus—Gemcitabine—kidney cancer	0.000451	0.000636	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—kidney cancer	0.000448	0.000632	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.000448	0.00227	CbGpPWpGaD
Icosapent ethyl—Dry mouth—Capecitabine—kidney cancer	0.000447	0.00063	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—kidney cancer	0.000446	0.000628	CcSEcCtD
Icosapent ethyl—Dizziness—Vincristine—kidney cancer	0.000445	0.000627	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—kidney cancer	0.000443	0.000624	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—kidney cancer	0.000443	0.000624	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Paclitaxel—kidney cancer	0.00044	0.00062	CcSEcCtD
Icosapent ethyl—Oedema—Capecitabine—kidney cancer	0.000438	0.000618	CcSEcCtD
Icosapent ethyl—Infection—Capecitabine—kidney cancer	0.000435	0.000614	CcSEcCtD
Icosapent ethyl—Shock—Capecitabine—kidney cancer	0.000431	0.000608	CcSEcCtD
Icosapent ethyl—Tachycardia—Capecitabine—kidney cancer	0.000428	0.000603	CcSEcCtD
Icosapent ethyl—Vomiting—Vincristine—kidney cancer	0.000427	0.000603	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—kidney cancer	0.000425	0.000599	CcSEcCtD
Icosapent ethyl—Rash—Vincristine—kidney cancer	0.000424	0.000598	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Capecitabine—kidney cancer	0.000424	0.000597	CcSEcCtD
Icosapent ethyl—Dermatitis—Vincristine—kidney cancer	0.000424	0.000597	CcSEcCtD
Icosapent ethyl—Body temperature increased—Paclitaxel—kidney cancer	0.000422	0.000595	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—kidney cancer	0.000418	0.000589	CcSEcCtD
Icosapent ethyl—Anorexia—Capecitabine—kidney cancer	0.000418	0.000589	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—kidney cancer	0.000416	0.000586	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—POMC—kidney cancer	0.000407	0.00206	CbGpPWpGaD
Icosapent ethyl—Vomiting—Gemcitabine—kidney cancer	0.000406	0.000572	CcSEcCtD
Icosapent ethyl—Rash—Gemcitabine—kidney cancer	0.000402	0.000567	CcSEcCtD
Icosapent ethyl—Dermatitis—Gemcitabine—kidney cancer	0.000402	0.000566	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000399	0.000563	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—kidney cancer	0.000399	0.000562	CcSEcCtD
Icosapent ethyl—Insomnia—Capecitabine—kidney cancer	0.000396	0.000559	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—kidney cancer	0.000395	0.000556	CcSEcCtD
Icosapent ethyl—Dyspnoea—Capecitabine—kidney cancer	0.000391	0.000551	CcSEcCtD
Icosapent ethyl—Dyspepsia—Capecitabine—kidney cancer	0.000386	0.000544	CcSEcCtD
Icosapent ethyl—Asthenia—Paclitaxel—kidney cancer	0.000383	0.00054	CcSEcCtD
Icosapent ethyl—Decreased appetite—Capecitabine—kidney cancer	0.000381	0.000537	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000378	0.000533	CcSEcCtD
Icosapent ethyl—Pruritus—Paclitaxel—kidney cancer	0.000378	0.000533	CcSEcCtD
Icosapent ethyl—Pain—Capecitabine—kidney cancer	0.000375	0.000528	CcSEcCtD
Icosapent ethyl—Constipation—Capecitabine—kidney cancer	0.000375	0.000528	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Capecitabine—kidney cancer	0.000361	0.000509	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—kidney cancer	0.000357	0.000503	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—kidney cancer	0.000355	0.000501	CcSEcCtD
Icosapent ethyl—Dizziness—Paclitaxel—kidney cancer	0.000353	0.000498	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—kidney cancer	0.000351	0.000495	CcSEcCtD
Icosapent ethyl—Body temperature increased—Capecitabine—kidney cancer	0.000346	0.000488	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—kidney cancer	0.000346	0.000488	CcSEcCtD
Icosapent ethyl—Vomiting—Paclitaxel—kidney cancer	0.00034	0.000479	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—kidney cancer	0.000339	0.000478	CcSEcCtD
Icosapent ethyl—Rash—Paclitaxel—kidney cancer	0.000337	0.000475	CcSEcCtD
Icosapent ethyl—Dermatitis—Paclitaxel—kidney cancer	0.000336	0.000474	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—kidney cancer	0.000335	0.000472	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—kidney cancer	0.000324	0.00164	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—kidney cancer	0.000321	0.000453	CcSEcCtD
Icosapent ethyl—Asthenia—Capecitabine—kidney cancer	0.000314	0.000443	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—kidney cancer	0.000312	0.00044	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—kidney cancer	0.000311	0.000438	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—kidney cancer	0.00031	0.000438	CcSEcCtD
Icosapent ethyl—Pruritus—Capecitabine—kidney cancer	0.00031	0.000437	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—kidney cancer	0.000304	0.000429	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—kidney cancer	0.000302	0.000426	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—kidney cancer	0.000299	0.000421	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—kidney cancer	0.000295	0.000415	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—kidney cancer	0.000295	0.000415	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—kidney cancer	0.000295	0.000415	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—kidney cancer	0.000291	0.00041	CcSEcCtD
Icosapent ethyl—Dizziness—Capecitabine—kidney cancer	0.00029	0.000409	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—kidney cancer	0.000288	0.000406	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTEN—kidney cancer	0.000283	0.00143	CbGpPWpGaD
Icosapent ethyl—Oedema—Doxorubicin—kidney cancer	0.000282	0.000398	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—kidney cancer	0.000282	0.000398	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—kidney cancer	0.000281	0.000396	CcSEcCtD
Icosapent ethyl—Vomiting—Capecitabine—kidney cancer	0.000279	0.000393	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—kidney cancer	0.000278	0.000392	CcSEcCtD
Icosapent ethyl—Rash—Capecitabine—kidney cancer	0.000276	0.00039	CcSEcCtD
Icosapent ethyl—Dermatitis—Capecitabine—kidney cancer	0.000276	0.000389	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—kidney cancer	0.000276	0.000389	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—kidney cancer	0.000273	0.000385	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—kidney cancer	0.000269	0.00038	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000257	0.000363	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—kidney cancer	0.000256	0.00036	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—kidney cancer	0.000252	0.000355	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—kidney cancer	0.000249	0.000351	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—kidney cancer	0.000246	0.000346	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000244	0.000344	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—kidney cancer	0.000242	0.000341	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—kidney cancer	0.000242	0.000341	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—kidney cancer	0.000233	0.000328	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—kidney cancer	0.000223	0.000315	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—kidney cancer	0.000203	0.000286	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—kidney cancer	0.0002	0.000282	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—kidney cancer	0.0002	0.00101	CbGpPWpGaD
Icosapent ethyl—Dizziness—Doxorubicin—kidney cancer	0.000187	0.000263	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—kidney cancer	0.00018	0.000253	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—kidney cancer	0.000178	0.000251	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—kidney cancer	0.000178	0.000251	CcSEcCtD
